Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Wenzhou
Clinical trial register · China

Clinical Trials in Wenzhou, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19187 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:17 UTC
19187
Studies in scope
all four open statuses
11790
Recruiting now
open to new participants
2028
Lead sponsors
across recruiting studies
Top sites
Beijing 5576 Shanghai 3879 Guangzhou 3345 Hangzhou 1819 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Second Affiliated Hospital of Wenzhou Medical University34 First Affiliated Hospital of Wenzhou Medical University28 The Eye Hospital of Wenzhou Medical University9 Janssen Research & Development, LLC6 Wenzhou Medical University5
Site location
Beijing5576 Shanghai3879 Guangzhou3345 Hangzhou1819 Wuhan1343
All 625 locations
Target enrolment
to

Trials with a site in Wenzhou

188 of 19187 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
100
Wenzhou
2027-01-01
Not yet open
Toripalimab ± Sequential Intravesical Gemcitabine-Mitomycin C for BCG-Unresponsive/-Intolerant High-Risk NMIBC: Open-Label Randomized Phase 2 Study
NCT07189793Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Carcinoma in Situ of Bladder, Non-Muscle-Invasive Bladder Cancer
DrugsMitomycin C·JS001·Toripalimab·Gemcitabine
First Affiliated Hospital of Wenzhou Medical University
Phase 2
106
Wenzhou
2026-12
Not yet open
First Affiliated Hospital of Wenzhou Medical University
Not applicable
286
Wenzhou
2026-12
Not yet open
Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia
NCT07827521Chronic Limb-Threatening Ischemia, Diabetic Foot Ulcer, Infrapopliteal Arterial Occlusive Disease
First Affiliated Hospital of Wenzhou Medical University
Phase 4
180
Hangzhou, Taizhou, Wenzhou
2026-10-20
By invitation
Second Affiliated Hospital of Wenzhou Medical University
Phase 1/2
2
Wenzhou
2026-10-20
Not yet open
LaNova Medicines Limited
Phase 1/2
90
Beijing, Xinxiang, Shiyan, Changsha, Liaocheng, Shanghai, Wenzhou
2026-10-19
Not yet open
Nutritional Intervention for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
NCT07850375Hematopoietic Stem Cell Transplantation (HSCT), Malnutrition (Calorie)
Institute of Hematology & Blood Diseases Hospital, China
Not applicable
160
Changchun, Tianjin, Wenzhou
2026-10-12
Recruiting
The Safety of Simplified Tranexamic Acid Regimen
NCT07869537Trauma Coagulopathy, Hemorrhage
DrugTranexamic Acid
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 4
60
Hangzhou, Jiaxin, Wenzhou
2026-10-01
Not yet open
First Affiliated Hospital of Wenzhou Medical University
Phase 1/2
96
Wenzhou
2026-10-01
Recruiting
Yongquan Shi
Phase 4
448
Zhengzhou, Xi'an, Wenzhou, Beijing, Chongqing, Foshan, Fujian, Guangzhou
2026-10-01
Not yet open
First Affiliated Hospital of Wenzhou Medical University
Not applicable
212
Shijiazhuang, Jinan, Wenzhou, Beijing, Chongqing
2026-10
Not yet open
First Affiliated Hospital of Wenzhou Medical University
Early Phase 1
18
Wenzhou
2026-09-30
Recruiting
Janssen Research & Development, LLC
Phase 2
100
Guangzhou, Wenzhou
2026-09-16
Recruiting
Jiangsu HengRui Medicine Co., Ltd.
Phase 3
320
Changsha, Wenzhou
2026-09-02
Not yet open
AI-Assisted Patient Support in mHSPC
NCT07804030Metastatic Prostate Cancer
Fudan University
Not applicable
160
Fuzhou, Shanghai, Kunming, Wenzhou
2026-09
Not yet open
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
Phase 1
48
Guangzhou, Nanchang, Shanghai, Wenzhou, Xi'an
2026-08-31
Not yet open
Wanbangde Pharmaceutical Group Co., LTD
Phase 1
40
Wenzhou
2026-08-25
Recruiting
DEC003M in Prostate Cancer
NCT07657806Advanced Prostate Cancer
Hangzhou DAC Biotechnology Co., Ltd.
Phase 1
110
Beijing, Suzhou, Chengdu, Hangzhou, Wenzhou, Chongqing
2026-08-19
Recruiting
Eli Lilly and Company
Phase 3
1,000
Beijing, Chaohu, Jinan, Linfen, Shanghai, Suzhou, Tianjin, Wenzhou
2026-08-14
Recruiting
Second Affiliated Hospital of Wenzhou Medical University
Observational
97
Wenzhou
2026-07-31
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
19
Beijing, Chengdu, Dongguan, Jinan, Shanghai, Shijiazhuang, Taiyuan, Wenzhou
2026-07-20
Recruiting
The First Affiliated Hospital of Anhui Medical University
Phase 4
285
Hefei, Taiyuan, Wenzhou, Chongqing
2026-07-16
Recruiting
A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors
NCT07518043Esophageal and/or Cardia Cancer, Melanoma, Urothelial Carcinoma (UC)
DrugOpdivo
Shanghai Henlius Biotech
Phase 1
174
Fuzhou, Hangzhou, Luoyang, Tianjin, Wenzhou, Wuhan, Xi'an
2026-07-15
Recruiting
Safety and Efficacy of Eculizumab in High-risk TA-TMA
NCT07707687Transplant-Associated Thrombotic Microangiopathy (TA-TMA)
DrugEculizumab
First Affiliated Hospital of Zhejiang University
Phase 2
24
Changsha, Hangzhou, Jinhua, Ningbo, Wenzhou
2026-07-10
Recruiting
Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors
NCT07692841Healthy Hematopoietic Stem Cell Donor, Healthy Allogeneic Hematopoietic Stem Cell Donor
DrugG-Csf
First Affiliated Hospital of Zhejiang University
Phase 3
560
Changsha, Hangzhou, Jinhua, Ningbo, Wenzhou
2026-07-10
Recruiting
First Affiliated Hospital of Wenzhou Medical University
Observational
4,600
Wenzhou
2026-06-17
Not yet open
Chinese University of Hong Kong
Phase 2
200
Hefei, Wenzhou
2026-06-15
Recruiting
Innatus Therapeutics (Shanghai) Co., Ltd.
Phase 1/2
24
Guangzhou, Shenyang, Beijing, Hangzhou, Shanghai, Taiyuan, Weifang, Wenzhou
2026-06-11
Recruiting
Novartis Pharmaceuticals
Phase 4
36
Guangzhou, Shijiazhuang, Chengdu, Hangzhou, Ningbo, Wenzhou, Beijing, Shanghai
2026-06-01
Recruiting
Surgery Plus Postoperative Radiotherapy for T4 Sinonasal Adenoid Cystic Carcinoma
NCT07652489Adenoid Cystic Carcinoma, Sinonasal Carcinoma
Eye & ENT Hospital of Fudan University
Observational
70
Harbin, Changsha, Shenyang, Shanghai, Xi’an, Wenzhou
2026-06-01
Not yet open
Edaravone Dexborneol for Post-Stroke Epilepsy
NCT07604350Post-stroke Epilepsy, Post-stroke Seizure
First Affiliated Hospital of Wenzhou Medical University
Phase 3
160
Wenzhou
2026-06
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
264
Fuzhou, Hangzhou, Huzhou, Jinhua, Ningbo, Wenzhou
2026-05-07
Recruiting
Eli Lilly and Company
Phase 2
60
Changsha, Changzhou, Guangzhou, Hangzhou, Huizhou, Suzhou, Wenzhou, Xiamen
2026-05-04
Recruiting
Eli Lilly and Company
Phase 2
60
Changsha, Changzhou, Guangzhou, Hangzhou, Huizhou, Suzhou, Wenzhou, Xiamen
2026-05-04
Not yet open
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
118
Hangzhou, Fuzhou, Huzhou, Jinhua, Ningbo, Wenzhou
2026-05-01
Recruiting
First Affiliated Hospital of Wenzhou Medical University
Phase 2
134
Wenzhou
2026-04-30
Not yet open
Second Affiliated Hospital of Wenzhou Medical University
Observational
2,100
Wenzhou
2026-04-10
Not yet open
Clinical Trial on Safety and Efficacy of Thoracoabdominal Endoscopic Surgical System for Pediatric Surgery
NCT07530133Indications for Laparoscopic Thoracic and Abdominal Surgery in Children, Congenital or Acquired Surgical Conditions Requiring Minimally Invasive Surgery in Children, Pyeloplasty, Ureteral Reimplantation
Hangzhou Kangji Weijing Medical Robotics Co., Ltd.
Not applicable
64
Wuhan, Hangzhou, Wenzhou
2026-04-09
Active, closed
A Study of CS060380 Tablets in Patients With MASH and Obesity
NCT07466017Metabolic Dysfunction-associated Steatohepatitis (MASH), Obesity
DrugsCS060380·Semaglutide
Cascade Pharmaceuticals, Inc
Phase 2
130
Hefei, Guangzhou, Shijiazhuang, Nanjing, Shanghai, Hangzhou, Ningbo, Wenzhou
2026-04-02
Not yet open
Zhejiang University
Not applicable
430
Hangzhou, Wenzhou, Chongqing
2026-04-01
Recruiting
Intelligence System for Predicting Atezolizumab-Bevacizumab Response and Clinical Outcomes in Unresectable Hepatocellular Carcinoma
NCT07495735HCC - Hepatocellular Carcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma
First Affiliated Hospital of Wenzhou Medical University
Observational
400
Wenzhou
2026-03-22
Recruiting
A Phase II Trial of G01 Eye Drops for Glaucomatous Optic Neuropathy
NCT07777861Primary Open-Angle Glaucoma, Optic Nerve Injury
Qingdao WanMing BioCell Pharmaceutics Co.,Ltd.
Phase 2
90
Beijing, Guangzhou, Shantou, Changsha, Tianjin, Hangzhou, Wenzhou
2026-03-18
Active, closed
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
66
Wenzhou
2026-03-06
Not yet open
The Efficacy and Safety of Infliximab Combination With Azathioprine in Crohn's Disease in Children
NCT07424040Crohn's Diseases, Crohn's Disease in Pediatric Patient
DrugInfliximab
The Children's Hospital of Zhejiang University School of Medicine
Not applicable
154
Kunming, Hangzhou, Jinhua, Wenzhou
2026-03-01
Recruiting
Application of Precision Partial Intersphincteric Resection (PPISR)
NCT07849023Low Rectal Cancer, Rectal Cancer Patients
First Affiliated Hospital of Wenzhou Medical University
Not applicable
100
Wenzhou
2026-02-08
Recruiting
Eli Lilly and Company
Phase 1
68
Beijing, Changsha, Hefei, Shanghai, Wenzhou, Wuhan
2026-02-04
Recruiting
Janssen Research & Development, LLC
Phase 3
400
Beijing, Chengdu, Guangzhou, Hangzhou, Nanjing, Nanning, Shanghai, Wenzhou
2026-02-04
Recruiting
Hoffmann-La Roche
Observational
500
Xiamen, Lanzhou, Shijiazhuang, Changchun, Wenzhou, Beijing, Chengdu, Chongqing
2026-01-21
Recruiting
The Effects of Anesthesia Type on the Prognosis of Hip Fracture Surgery on Elderly Patients
NCT03116490Postoperative Complications, Postoperative Mortality
Wenzhou Medical University
Observational
600
Wenzhou
2026-01-16
Not yet open
Stereotactic Aspiration of Brain Stem Hematoma
NCT07300501Brain Stem Hematoma
First Affiliated Hospital of Zhejiang University
Not applicable
300
Hangzhou, Changsha, Guangzhou, Jinan, Shanghai, Shenzhen, Taizhou, Wenzhou
2026-01-01
Not yet open
First Affiliated Hospital of Wenzhou Medical University
Not applicable
150
Wenzhou
2026-01-01
Recruiting
Evaluating the Efficacy and Safety of Lecanemab in Alzheimer's Disease Through Multi-omics Approachs
NCT07604896Alzheimer s Disease, Alzheimer Dementia (AD), MCI-AD, Early Stage Alzheimer's Disease
DrugLecanemab
First Affiliated Hospital of Wenzhou Medical University
Phase 4
200
Wenzhou
2026-01-01
Not yet open
First Affiliated Hospital of Wenzhou Medical University
Phase 4
224
Wenzhou
2026-01
Recruiting
Daiichi Sankyo
Phase 1
60
Guangzhou, Shanghai, Wenzhou
2025-12-03
Active, closed
Novartis Pharmaceuticals
Phase 2
234
Luoyang, Shenyang, Wenzhou, Beijing
2025-12-02
Recruiting
First Affiliated Hospital of Wenzhou Medical University
Phase 2
30
Wenzhou
2025-12-01
Not yet open
First Affiliated Hospital of Wenzhou Medical University
Phase 2
302
Wenzhou
2025-12
Recruiting
First Affiliated Hospital of Wenzhou Medical University
Not applicable
90
Wenzhou
2025-11-05
Active, closed
Second Affiliated Hospital of Wenzhou Medical University
Observational
100
Wenzhou
2025-11-01
Recruiting
Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.
NCT07569653Cytomegalovirus Infections, Cytomegalovirus Disease, Hematopoietic Stem Cell Transplantation, Graft vs Host Disease
WeiShi
Phase 4
120
Beijing, Shijiazhuang, Zhengzhou, Jingzhou, Wuhan, Hohhot, Nanchang, Wenzhou
2025-10-30
Recruiting
Gracell Biotechnologies (Shanghai) Co., Ltd.
Phase 1
12
Beijing, Changchun, Guangzhou, Hangzhou, Suzhou, Wenzhou, Wuhan
2025-10-29
Recruiting
PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer
NCT07775820Lung Cancer, Rechallenge, Checkpoint Inhibitor Pneumonitis
Nanfang Hospital, Southern Medical University
Observational
150
Guangzhou, Shenzhen, Nanchang, Wenzhou
2025-10-20
Recruiting
A Study of LUCAR-DKS1 in Subjects With Relapsed/Refractory Autoimmune Diseases
NCT07095075Relapsed/Refractory Autoimmune Diseases
Nanjing Legend Biotech Co.
Early Phase 1
36
Bengbu, Hefei, Nanjing, Suzhou, Wenzhou
2025-10-14
Recruiting
Novartis Pharmaceuticals
Phase 3
300
Beijing, Guangzhou, Luoyang, Xuzhou, Nanchang, Wenzhou, Fuzhou, Jining
2025-10-03
Recruiting
First Affiliated Hospital of Wenzhou Medical University
Phase 2
240
Wenzhou
2025-10-01
Not yet open
First Affiliated Hospital of Wenzhou Medical University
Not applicable
140
Wenzhou
2025-10
Active, closed
Cascade Pharmaceuticals, Inc
Phase 2
120
Fuzhou, Xiamen, Suzhou, Shanghai, Hangzhou, Wenzhou
2025-09-30
Recruiting
Janssen Research & Development, LLC
Phase 3
220
Beijing, Chengdu, Guangzhou, Nanjing, Ningbo, Tianjin, Wenzhou, Wuhan
2025-09-10
Recruiting
First Affiliated Hospital of Wenzhou Medical University
Phase 4
220
Wenzhou
2025-09-01
Not yet open
Liu Zhanghong
Early Phase 1
70
Hangzhou, Wenzhou
2025-09-01
Recruiting
Jing Tao
Not applicable
180
Fuzhou, Wenzhou
2025-08-27
Recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
112
Beijing, Guangzhou, Shantou, Nanning, Guiyang, Haikou, Wenzhou, Shenzhen
2025-08-15
Recruiting
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
144
Wenzhou
2025-08-02
Not yet open
29-Gene Liver Cancer Subtype and Immunotherapy Effectiveness
NCT07100236Primary Hepatocellular Carcinoma
Junjie Xu
Observational
350
Hefei, Chaoyang, Fuzhou, Guangzhou, Zhengzhou, Shanghai, Hangzhou, Wenzhou
2025-08-01
Recruiting
Tasly Biopharmaceuticals Co., Ltd.
Phase 1
32
Beijing, Guangzhou, Datong, Tianjin, Wenzhou
2025-07-24
Recruiting
Gang Chen, MD
Observational
2,000
Wenzhou
2025-07-22
Recruiting
Effect of Adenotonsillectomy on Spinal Curve Magnitude in Children With Sleep-Disordered Breathing
NCT07332780Sleep-disordered Breathing (SDB), Idiopathic Scoliosis, Obstructive Sleep Apnea (OSA)
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
160
Wenzhou
2025-07-11
Active, closed
The A.R.R.E.S.T.® Contact Lens Study
NCT06878118Myopia, Myopia Progression
nthalmic Pty Ltd
Not applicable
80
Wenzhou
2025-07-06
Not yet open
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 1
180
Wenzhou, Shanghai
2025-07
By invitation
Wenzhou Central Hospital
Observational
10
Wenzhou
2025-06-28
Not yet open
Effect of Sevoflurane on Sweat Threshold in Children of Different Ages
NCT07035782Child, Only, Temperature Regulation; Disorder, Low Body Temperatures, Sevoflurane
DrugSevoflurane
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
100
Wenzhou
2025-06
Recruiting
Effect of Vitamin A Supplementation on Idiopathic Scoliosis
NCT07335991Vitamin A Deficiency, Idiopathic Scoliosis
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
140
Wenzhou
2025-05-13
Active, closed
Hoffmann-La Roche
Phase 1
20
Guangzhou, Tianjin, Nanchang, Wenzhou, Wuhan
2025-05-13
Recruiting
Guangzhou 8th People's Hospital
Not applicable
210
Guangzhou, Shenzhen, Shijiazhuang, Changsha, Wenzhou, Beijing
2025-05-03
Not yet open
Ruijin Hospital
Not applicable
212
Luoyang, Jinan, Shanghai, Wenzhou
2025-05
Recruiting
Shanghai BDgene Co., Ltd.
Phase 2
40
Wenzhou
2025-04-28
By invitation
Second Affiliated Hospital of Wenzhou Medical University
Phase 4
148
Wenzhou
2025-04-25
Recruiting
Shanghai Zhongshan Hospital
Phase 2
150
Xiamen, Shanghai, Wenzhou
2025-04-16
Not yet open
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
63
Wenzhou
2025-04-10
Recruiting
A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD
NCT06346600Neovascular (Wet) Age-related Macular Degeneration
Skyline Therapeutics
Observational
83
Hefei, Hangzhou, Wenzhou, Beijing, Shanghai
2025-04-02
Recruiting
Sir Run Run Shaw Hospital
Phase 2
70
Guangzhou, Zhengzhou, Wuhan, Changsha, Hangzhou, Wenzhou
2025-04-01
Recruiting
Jianmin Pharmaceutical Group Co., LTD.
Phase 2
216
Harbin, Changsha, Changchun, Jinan, Luzhou, Tianjin, Wenzhou
2025-03-26
Recruiting
Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
Phase 2
119
Wenzhou
2025-03-24
Recruiting
Second Affiliated Hospital of Wenzhou Medical University
Phase 4
80
Wenzhou
2025-03-01
Recruiting
Chen Wei
Observational
150
Wenzhou
2025-03-01
Active, closed
Medtronic Cardiac Rhythm and Heart Failure
Observational
50
Wenzhou, Shanghai
2025-02-26
Recruiting
AI-Assisted Medical Decision-Making
NCT06846229Real-world Study
The Eye Hospital of Wenzhou Medical University
Observational
50,000,000
Wenzhou
2025-02-24
By invitation
Second Affiliated Hospital of Wenzhou Medical University
Phase 1
6
Wenzhou
2025-02-06
Not yet open
Second Affiliated Hospital of Wenzhou Medical University
Phase 4
96
Wenzhou
2025-02
Recruiting
The Eye Hospital of Wenzhou Medical University
Observational
1,000,000
Guangzhou, Chengdu, Wenzhou
2025-01-19
Active, closed
Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD
NCT06724809NMOSD, Neuromyelitis Optica Spectrum Disorders
DrugEculizumab
Alexion Pharmaceuticals, Inc.
Phase 3
21
Beijing, Dongguan, Jinan, Shanghai, Taiyuan, Wenzhou, Wuhan
2025-01-16
Recruiting
Peking Union Medical College Hospital
Not applicable
40
Beijing, Wenzhou
2025-01-09
Recruiting
Peking University First Hospital
Phase 4
84
Changsha, Jinan, Chengdu, Ürümqi, Wenzhou, Beijing, Shanghai
2025-01-07
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
38
Yangzhou, Shanghai, Hangzhou, Huzhou, Jiaxing, Ningbo, Wenzhou
2025-01-06
Not yet open
Second Affiliated Hospital of Wenzhou Medical University
Observational
119
Wenzhou
2024-12-20
Recruiting
The Eye Hospital of Wenzhou Medical University
Observational
5,000,000
Zhuhai, Wenzhou
2024-12-20
Recruiting
The Eye Hospital of Wenzhou Medical University
Not applicable
100,000
Zhuhai, Wenzhou
2024-12-01
Active, closed
Wenzhou Medical University
Observational
96
Wenzhou
2024-12-01
Recruiting
BeOne Medicines
Phase 1/2
80
Fuzhou, Guangzhou, Suzhou, Hangzhou, Wenzhou
2024-11-27
Recruiting
The EEG Study Under Remimazolam Anesthesia in Children
NCT06698705Electroencephalography, Remimazolam, Child Neglect
Second Affiliated Hospital of Wenzhou Medical University
Observational
60
Wenzhou
2024-11-22
Recruiting
Study on Aging and Cognitive Impairment in China
NCT06679296Cognitive Dysfunction, Aging
First Affiliated Hospital of Wenzhou Medical University
Observational
20,000
Wenzhou
2024-11-20
Not yet open
First Affiliated Hospital of Wenzhou Medical University
Observational
100
Wenzhou
2024-11
Recruiting
Second Affiliated Hospital of Wenzhou Medical University
Observational
3,000
Wenzhou
2024-10-05
Active, closed
Wenzhou Medical University
Observational
68
Wenzhou
2024-10-01
Recruiting
Zhejiang Adolescent Spine and Vision Health Cohort: A Longitudinal Database Analysis
NCT06992622Scoliosis Idiopathic, Myopia, Vision Disorders
Second Affiliated Hospital of Wenzhou Medical University
Observational
73,000
Wenzhou
2024-09-30
Recruiting
Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)
NCT06726421Renal Cell Carcinoma (Kidney Cancer), Kidney Cancer Metastatic, Renal Cell Carcinoma Metastatic
Sun Yat-sen University
Phase 3
252
Fuzhou, Guangzhou, Wuhan, Changchun, Chengdu, Wenzhou, Beijing, Shanghai
2024-09-18
Recruiting
The EEG Study Under Sevoflurane Anesthesia in Children
NCT06580028Electroencephalography, Sevoflurane, Child Neglect
Second Affiliated Hospital of Wenzhou Medical University
Observational
280
Wenzhou
2024-09-04
Recruiting
First Affiliated Hospital of Wenzhou Medical University
Observational
216
Wenzhou
2024-09-02
Not yet open
Shanghai Chest Hospital
Not applicable
134
Wuhan, Nanchang, Shanghai, Ürümqi, Wenzhou
2024-09-01
Recruiting
Suzhou Forlong Biotechnology Co., Ltd
Phase 1/2
80
Beijing, Fuzhou, Wenzhou, Changsha, Nanjing, Suzhou, Qingdao, Chengdu
2024-08-16
Recruiting
Idiopathic Scoliosis New Onset and Melatonin Phase Delay in Children
NCT06502613Scoliosis Idiopathic, Circadian Rhythm, Melatonin
Second Affiliated Hospital of Wenzhou Medical University
Observational
956
Wenzhou
2024-08-01
By invitation
Second Affiliated Hospital of Wenzhou Medical University
Early Phase 1
10
Wenzhou
2024-07-01
Recruiting
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
222
Hangzhou, Ningbo, Wenzhou
2024-06-25
Not yet open
The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases
NCT06420154Systemic Lupus Erythematosus (SLE), Sjogren's Syndrome, Systemic Sclerosis, Inflammatory Myopathy
First Affiliated Hospital of Wenzhou Medical University
Early Phase 1
9
Wenzhou
2024-05-27
Recruiting
AMT-116 in Patients with Solid Tumors
NCT06782334Advanced Solid Tumors
DrugAMT-116
Multitude Therapeutics Inc.
Phase 1/2
144
Fuzhou, Dongguan, Guangzhou, Nanning, Changsha, Hangzhou, Wenzhou
2024-05-07
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1
500
Beijing, Hangzhou, Wenzhou, Chengdu, Guangzhou
2024-05-01
Active, closed
Janssen Research & Development, LLC
Phase 3
272
Beijing, Cheng Du Shi, Chongqing, Guangzhou, Shenyang, Tianjin, Wenzhou, Wuhan
2024-04-09
Recruiting
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 2
80
Zhengzhou, Nanjing, Suzhou, Shanghai, Wenzhou
2024-03-19
Recruiting
AstraZeneca
Phase 3
100
Beijing, Changchun, Changsha, Dongguan, Nanjing, Shanghai, Suzhou, Wenzhou
2024-03-14
Recruiting
Skyline Therapeutics (US) Inc.
Phase 1/2
68
Hefei, Hangzhou, Wenzhou, Beijing
2024-02-23
Recruiting
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
166
Wenzhou
2024-01-28
Recruiting
Second Affiliated Hospital of Wenzhou Medical University
Phase 2/3
10
Wenzhou
2024-01-01
Not yet open
Second Affiliated Hospital of Wenzhou Medical University
Observational
200
Wenzhou
2024-01-01
Recruiting
First Affiliated Hospital of Wenzhou Medical University
Phase 4
1,500
Ningbo, Rui’an, Wenzhou, Yueqing
2024-01-01
Recruiting
Elderly Patients Undergoing Surgery During Perioperative Period
NCT07314762Postoperative Complications, Elderly, Postoperative Delirium (POD), Risk Prediction Model
Second Affiliated Hospital of Wenzhou Medical University
Observational
1,200
Wenzhou
2023-12-30
Recruiting
Gracell Biotechnologies (Shanghai) Co., Ltd.
Phase 1/2
110
Beijing, Hangzhou, Jinan, Shanghai, Shenyang, Wenzhou, Wuhan, Xi'an
2023-12-26
Recruiting
Nab-paclitaxel Versus Sb-taxanes As First-Line Treatment in Advanced Ovarian Cancer
NCT05737303Epithelial Ovarian Carcinoma Stage III, Epithelial Ovarian Carcinoma Stage IV, Fallopian Tube Carcinoma Stage III, Fallopian Tube Carcinoma Stage IV
DrugsNab-paclitaxel·Carboplatin
Women's Hospital School Of Medicine Zhejiang University
Phase 3
538
Guangzhou, Ji'nan, Hangzhou, Ningbo, Wenzhou
2023-11-27
By invitation
Second Affiliated Hospital of Wenzhou Medical University
Observational
1,000
Wenzhou
2023-11-27
Recruiting
Janssen Research & Development, LLC
Phase 1
355
Chongqing, Wenzhou, Xi'an
2023-11-01
Recruiting
Mao Jianhua
Phase 3
140
Wuhan, Nanjing, Kunming, Hangzhou, Ningbo, Wenzhou, Beijing, Shanghai
2023-11-01
Recruiting
Effect of FPCA on Incidence of Emergency Delirium in Children After Surgery
NCT06092671Postoperative Complications, Child, Family, Emergence Delirium
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
444
Wenzhou
2023-10-24
Recruiting
First Affiliated Hospital of Zhejiang University
Observational
2,000
Hangzhou, Huzhou, Jiaxing, Lanxi, Lishui, Pinghu, Taizhou, Wenzhou
2023-09-25
Recruiting
Comparison of 5-ALA Photodynamic Therapy and CO2 Laser for Treating Persistent Low-Grade Cervical Lesions With High-Risk HPV Infection
NCT06052033HPV-Related Cervical Carcinoma, Low-Grade Squamous Intraepithelial Lesions, HPV Infection, Photodynamic Therapy
First Affiliated Hospital of Wenzhou Medical University
Not applicable
40
Wenzhou
2023-09-11
Active, closed
Shanghai BDgene Co., Ltd.
Phase 1
16
Shanghai, Hangzhou, Wenzhou
2023-09-04
Recruiting
Qilu Pharmaceutical Co., Ltd.
Phase 3
735
Wenzhou
2023-08-20
Active, closed
nthalmic Pty Ltd
Not applicable
441
Wenzhou, Tianjin, Shanghai
2023-08-04
Recruiting
Early Diagnosis and Prediction of Maternal and Neonatal Diseases:
NCT06791343Pregnancy-Related and Neonatal Disorders
The Eye Hospital of Wenzhou Medical University
Observational
1,000,000
Guangzhou, Wenzhou
2023-08-01
Recruiting
The Eye Hospital of Wenzhou Medical University
Observational
100,000
Guangzhou, Wenzhou
2023-07-01
Recruiting
The Eye Hospital of Wenzhou Medical University
Observational
2,000,000
Guangzhou, Chengdu, Wenzhou
2023-07-01
Recruiting
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
40
Wenzhou
2023-05-20
Active, closed
Wenzhou Gestational Diabetes Cohort
NCT05794152Gestational Diabetes Mellitus, Intrauterine Hyperglycemia, Birth Outcome, Adverse, Nutrition, Healthy
Westlake University
Not applicable
300
Wenzhou
2023-03-21
Recruiting
The Eye Hospital of Wenzhou Medical University
Observational
1,000,000
Guangzhou, Wenzhou
2023-03-01
Recruiting
AI-Driven Prediction of Hospital-Acquired Infections With EHR
NCT06791382Hospital-acquired Infections
The Eye Hospital of Wenzhou Medical University
Observational
1,000,000
Wenzhou
2023-02-01
Active, closed
Pfizer
Phase 1
148
Hangzhou, Wenzhou
2022-11-30
Active, closed
LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB
NCT05572957Non-ischemic Cardiomyopathy, Heart Failure, Left Bundle-Branch Block
DrugGDMT
The First Affiliated Hospital with Nanjing Medical University
Not applicable
50
Beijing, Fuzhou, Nanjing, Dalian, Chengdu, Wenzhou
2022-10-14
Active, closed
Hoffmann-La Roche
Phase 3
122
Beijing, Chengdu, Fuzhou, Jining, Shanghai, Wenzhou
2022-09-27
Recruiting
Dual-port Trans-subclavian Thyroid Endoscopic Surgery
NCT06398795Thyroid Neoplasms, Endoscopic Surgery
First Affiliated Hospital of Wenzhou Medical University
Not applicable
300
Wenzhou
2022-09-01
Recruiting
Zhejiang Provincial People's Hospital
Phase 2
80
Qingdao, Hangzhou, Ningbo, Tianjin, Wenzhou
2022-09-01
Active, closed
GlaxoSmithKline
Phase 3
163
Beijing, Guangzhou, Hefei, Nanjing, Qingdao, Shanghai, Shenzhen, Wenzhou
2022-07-14
Recruiting
Hrain Biotechnology Co., Ltd.
Phase 2
100
Shanghai, Wenzhou
2022-07-12
Active, closed
Cloudbreak Therapeutics, LLC
Phase 3
660
Beijing, Chengdu, Haikou, Hengyang, Kunming, Nanchang, Qingdao, Wenzhou
2022-06-30
Active, closed
Celgene
Phase 3
939
Changsha, Nanchang, Xi'an, Shanghai, Taiyuan, Wenzhou, Beijing, Changchun
2022-06-23
Recruiting
A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery
NCT05242419Injection, Non-cardiac Surgery, Delirium in Old Age, Post Operative Delirium
DrugHuperzine A
Second Affiliated Hospital of Wenzhou Medical University
Not applicable
40
Wenzhou
2022-06-10
Recruiting
Chinese University of Hong Kong
Phase 2
110
Wenzhou
2022-05-25
By invitation
AstraZeneca
Phase 3
214
Beijing, Changsha, Hangzhou, Nanjing, Shanghai, Shenyang, Wenzhou, Xi'an
2022-04-19
Active, closed
Pfizer
Phase 3
854
Guangzhou, Tianjin, Wenzhou
2022-03-25
Recruiting
Genor Biopharma Co., Ltd.
Phase 3
350
Bengbu, Hefei, Beijing, Chongqing, Fuzhou, Wenzhou, Xiamen, Foshan
2022-01-14
Active, closed
Novartis Pharmaceuticals
Phase 3
1,007
Wuhan, Nanjing, Yinchuan, Taiyuan, Hangzhou, Wenzhou, Beijing, Shanghai
2021-12-13
Recruiting
Wang Ouchen
Not applicable
154
Wenzhou
2021-11-27
Recruiting
Immune Score Based Radiomics in Nasopharyngeal Carcinoma
NCT05126160Nasopharyngeal Carcinoma
Zhejiang Cancer Hospital
Observational
494
Wuhan, Ningbo, Wenzhou, Hangzhou
2021-11-05
Active, closed
Anlotinib Capsules in the Treatment for IPF/PF-ILDs
NCT05828953Interstitial Lung Diseases
DrugAnlotinib
First Affiliated Hospital of Wenzhou Medical University
Phase 2
30
Wenzhou
2021-09-28
Recruiting
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
NCT05006716B-cell Malignancy, Marginal Zone Lymphoma, Follicular Lymphoma, Non-Hodgkin Lymphoma
DrugTacabrutideg
BeOne Medicines
Phase 1/2
689
Beijing, Guangzhou, Zhengzhou, Yichang, Shanghai, Tianjin, Wenzhou
2021-09-13
Active, closed
Janssen Research & Development, LLC
Phase 1
216
Beijing, Chongqing, Guangzhou, Wenzhou
2021-07-13
Recruiting
Second Affiliated Hospital of Wenzhou Medical University
Observational
530
Wenzhou
2021-01-01
Recruiting
Lifetech Scientific (Shenzhen) Co., Ltd.
Observational
579
Jinan, Shanghai, Mianyang, Wenzhou
2020-11-12
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
281
Beijing, Guangzhou, Hangzhou, Shanghai, Suzhou, Wenzhou, Wuhan
2020-11-03
Active, closed
Alexion Pharmaceuticals, Inc.
Phase 3
125
Beijing, Guangzhou, Hangzhou, Wenzhou, Wuhan
2020-08-25
Recruiting
Amgen
Phase 1
479
Beijing, Guangzhou, Nanchang, Shanghai, Hangzhou, Nanjing, Wenzhou
2020-03-04
Recruiting
Basic and Clinical Research of Pregnancy-Induced Hypertension
NCT07464379Pregnancy-induced Hypertension
Second Affiliated Hospital of Wenzhou Medical University
Observational
100
Wenzhou
2020-01-01
Recruiting
CooperVision International Limited (CVIL)
Not applicable
250
Shanghai, Tianjin, Wenzhou
2019-08-29
Recruiting
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
35,000
Wuhan, Xining, Shanghai, Kunming, Wenzhou, Jinan
2019-06-01
Active, closed
Idiopathic Scoliosis Progression and Sleep-disordered Breathing in Children
NCT03858244Scoliosis Idiopathic, Sleep Disordered Breathing, Obstructive Sleep Apnea
Second Affiliated Hospital of Wenzhou Medical University
Observational
405
Wenzhou
2019-02-18
By invitation
Second Affiliated Hospital of Wenzhou Medical University
Observational
100
Wenzhou
2019-01-01
Recruiting
Wenzhou Medical University
Not applicable
60
Guangzhou, Changsha, Wenzhou, Beijing, Shanghai
2018-11-16
Active, closed
Centre Hospitalier Universitaire de Besancon
Not applicable
989
Hangzhou, Wenzhou
2018-05-03
Recruiting
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
NCT03460977Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC), Follicular Lymphoma (FL)
DrugsMevrometostat·Xtandi·Itraconazole·Enzalutamide
Pfizer
Phase 1
453
Guangzhou, Changsha, Nanjing, Chengdu, Wenzhou
2018-04-17
Recruiting
Wenzhou Medical University
Observational
70
Wenzhou
2017-10-10
Recruiting
University Hospital, Geneva
Observational
20,000
Wenzhou
2015-12-28
Rows per page Showing 1–188 of 188
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 8 November 2026. https://priyalifescience.com/clinical-trials-china/city/wenzhou

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,187 studies in total at the last sync on 08 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 188 of those studies with a site in Wenzhou.

How many clinical trials are recruiting in Wenzhou?

114 of the 188 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:17 UTC sync. A further 37 have not yet opened recruitment, 29 are active but closed to new participants, and 8 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Wenzhou), 188 studies
PhaseStudiesRecruitingShare
Observational483525.5%
Not applicable421922.3%
Phase 2251813.3%
Phase 3251313.3%
Phase 118109.6%
Phase 414107.4%
Phase 1/21075.3%
Early Phase 1512.7%
Phase 2/3110.5%

Most active sponsors

Lead sponsors with the most studies (Wenzhou)
Lead sponsorStudiesRecruiting
Second Affiliated Hospital of Wenzhou Medical University3418
First Affiliated Hospital of Wenzhou Medical University2814
The Eye Hospital of Wenzhou Medical University99
Janssen Research & Development, LLC64
Second Affiliated Hospital, Zhejiang University, School of Medicine53
Wenzhou Medical University53
Alexion Pharmaceuticals, Inc.41
Eli Lilly and Company44
First Affiliated Hospital of Zhejiang University43
Novartis Pharmaceuticals42
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.